Your browser doesn't support javascript.
loading
Genetic variants in the TNF pathway impact TNFi response in a mixed population with rheumatoid arthritis.
Augusto Silva Dos Santos Rodrigues, Pedro; Lima de Oliveira, Almirane; Mattos Brandão, Katarina; de Sá Garcia Landeiro, Lilian; Cardoso Calmon, Laryssa; Victor Andrade Cruz, João; Dos Anjos Silva, Mailane; Flávia Silva Rocha, Ana; Silva Carvalho de Souza, Deyse; Tupiná Alcântara de Moreira, Aramis; de Oliveira Santos, Junison; Miranda Barbosa Dos Santos, Thamara; Pimentel Pinheiro, Gabriela; Augusto Souza da Cruz Filho, Álvaro; Alexandrina Viana de Figueiredo, Camila; de Moura Santos, Pablo; Dos Santos Costa, Ryan.
Affiliation
  • Augusto Silva Dos Santos Rodrigues P; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Lima de Oliveira A; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Mattos Brandão K; Department of Medicine, School of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil.
  • de Sá Garcia Landeiro L; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Cardoso Calmon L; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Victor Andrade Cruz J; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Dos Anjos Silva M; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Flávia Silva Rocha A; Department of Medicine, School of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Silva Carvalho de Souza D; Centro de Infusões e Medicamentos Especializados Da Bahia (CIMEB), Directorate of Pharmaceutical Assistance, Health Secretary of the State of Bahia, Salvador, Bahia, Brazil.
  • Tupiná Alcântara de Moreira A; Centro de Infusões e Medicamentos Especializados Da Bahia (CIMEB), Directorate of Pharmaceutical Assistance, Health Secretary of the State of Bahia, Salvador, Bahia, Brazil.
  • de Oliveira Santos J; Centro de Infusões e Medicamentos Especializados Da Bahia (CIMEB), Directorate of Pharmaceutical Assistance, Health Secretary of the State of Bahia, Salvador, Bahia, Brazil.
  • Miranda Barbosa Dos Santos T; Centro de Infusões e Medicamentos Especializados Da Bahia (CIMEB), Directorate of Pharmaceutical Assistance, Health Secretary of the State of Bahia, Salvador, Bahia, Brazil.
  • Pimentel Pinheiro G; Programa de Controle Da Asma Na Bahia (ProAR), Federal University of Bahia, Salvador, Bahia, Brazil.
  • Augusto Souza da Cruz Filho Á; Programa de Controle Da Asma Na Bahia (ProAR), Federal University of Bahia, Salvador, Bahia, Brazil.
  • Alexandrina Viana de Figueiredo C; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
  • de Moura Santos P; Department of Medicine, School of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil.
  • Dos Santos Costa R; Department of Bioregulation, Laboratory of Immunopharmacology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil. Electronic address: ryan.costa@ufba.br.
Gene ; 928: 148804, 2024 Nov 30.
Article in En | MEDLINE | ID: mdl-39089529
ABSTRACT
Rheumatoid arthritis (RA) is a multifactorial autoimmune inflammatory disease that mainly affects the joints, on reducing functional capacity and impacting quality of life. Cytokines such as tumor necrosis factor (TNF) and interleukin 6 (IL-6) are crucial in the pathogenesis and treatment of this disease. Some patients using TNF inhibitors (TNFi) do not respond or lose their response to these medications. Clinical, sociodemographic, and genetic data were used to evaluate the associations of single nucleotide polymorphisms (SNP) in TNF, TNFRSF1A, and TNFRSF1B genes with the diagnosis of RA, standardized score results, laboratory tests, and response to TNFi. In one subsample, TNF and IL-6 serum levels cytokines were performed. A total of 654 subjects (360 healthy controls and 294 diagnosed with RA) were included in the analysis. Higher levels of TNF have been found in individuals diagnosed with RA. IL-6 levels were higher in individuals who did not respond to TNFi treatment, while responders had levels comparable to those without the disease. No associations were found between the SNPs studied and the diagnosis of RA; however, rs767455-C seems to play a role in the response to golimumab treatment, being related to better therapeutic response and lower mean serum leukocyte levels. In addition, rs1061622-G was associated with poorer functional capacity and rs1800629-A was associated with higher leukocyte values and serum transaminase levels. The rs1061622-G and rs767455-C may play a role in the response to TNFi treatment, especially for patients using golimumab, although they do not seem to be associated with the diagnosis of RA. Polymosphisms in the TNF pathway may impact baseline levels of immune cells and markers of renal and hepatic function in RA patients. Our results highlight the importance of evaluating the impact of these polymorphisms on TNFi response and safety, particularly in larger-scale studies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interleukin-6 / Tumor Necrosis Factor-alpha / Polymorphism, Single Nucleotide / Receptors, Tumor Necrosis Factor, Type II / Tumor Necrosis Factor Inhibitors Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Gene Year: 2024 Document type: Article Affiliation country: Brazil Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interleukin-6 / Tumor Necrosis Factor-alpha / Polymorphism, Single Nucleotide / Receptors, Tumor Necrosis Factor, Type II / Tumor Necrosis Factor Inhibitors Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Gene Year: 2024 Document type: Article Affiliation country: Brazil Country of publication: Netherlands